Slight to moderate elevations of plasma sCD163 are observed in obese adults with biopsy verified NAFLD and non-alcoholic steatohepatitis (NASH) and the plasma concentration reflects the severity of NAFLD [83,84,85] and levels are reduced after interventions [86,87]. Here, CD163 is linked to metabolic dysfunction-associated steatotic liver disease.